ALL ABOUT BLEEDING

Serial Number 97722573
733

Registration Progress

Application Filed
Dec 19, 2022
Under Examination
Aug 22, 2023
Approved for Publication
Jun 27, 2023
Published for Opposition
Jun 27, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Feb 22, 2026 189 days

Trademark Image

ALL ABOUT BLEEDING

Basic Information

Serial Number
97722573
Filing Date
December 19, 2022
Published for Opposition
June 27, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Jul 22, 2025
Application
Pending
Classes
016 035 041 042
+1 more

Rights Holder

CSL Behring L.L.C.

16
Address
1020 First Avenue
King of Prussia, PA 19406

Ownership History

CSL Behring L.L.C.

Original Applicant
16
King of Prussia, PA

CSL Behring L.L.C.

Owner at Publication
16
King of Prussia, PA

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

Next Deadline
189 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
February 22, 2026
Extension Available
Until August 22, 2024

Application History

30 events
Date Code Type Description Documents
Jul 22, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 22, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 22, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 22, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 4, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 22, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 22, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 22, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 17, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 17, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 17, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 17, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 24, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 22, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 22, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 22, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 22, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 27, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 27, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 7, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 23, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 21, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 20, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 20, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 7, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 7, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 7, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 4, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 15, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 22, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 016
Printed materials, namely, journals, newsletters, articles and case studies featuring blood related diseases, biopharmaceuticals and biotherapies; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of blood related diseases; printed educational materials in the field of blood related diseases
Class 035
Promoting public awareness of Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; promoting public awareness of Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals by means of public advocacy and patient and caregiver public advocacy; Promoting the donation of blood, volunteer services, and financial resources in the field of blood donations by means of arranging and conducting incentive reward programs
Class 041
Healthcare education services, namely, providing educational and awareness educational training programs for patients, caregivers and/or healthcare professionals concerning Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; organizing, planning and conducting educational conventions and educational seminars in the field of Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals
Class 042
Medical and scientific research in the field of health, wellness, and blood conditions
Class 044
Healthcare and healthcare information services, namely, providing healthcare information concerning Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; Providing a website featuring information in the field of health and medical conditions relating to the blood, bleeding conditions, and corresponding treatments; Healthcare and healthcare information services, namely, providing healthcare information concerning hemophilia, platelet dysfunction, perioperative bleeding, rare bleeding disorders, fibrinogen deficiency, anticoagulant reversal, and other blood related diseases, treatment and impacts on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing healthcare information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by bleeding conditions; Providing a website featuring healthcare information in the field of the diagnosis and treatment of blood conditions; Providing links to the web sites of others featuring information about the diagnosis and treatment of blood conditions and treatments

Classification

International Classes
016 035 041 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BLEEDING"